Streetbeat News

Stock Prices

INUV

INVO

The correct ticker symbol for INVO BioSciences is INVO, not INUV as may have been previously mentioned.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 3:10 pm

INVO

INVO BioSciences shares were halted and then resumed trading, triggering a circuit breaker due to a sharp increase in stock price, now up 154.7%.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 3:09 pm

CAPL

GPP

CrossAmerica Partners (NYSE:CAPL) is distributing a dividend of $0.53 per share with an annualized yield of 9.60%, payable to shareholders who held the stock before November 2, 2023. The company has maintained a stable dividend per share of $2.10 from 2019 to 2022 and has shown positive earnings growth, with earnings per share increasing from $0.60 to $1.51 over the same period. Green Plains Partners (NASDAQ:GPP) has the highest annualized dividend yield in the industry at 13.98%.

Portfolio Pulse from Benzinga Insights

November 10, 2023 | 3:05 pm

BMRC

WTBA

Bank of Marin (NASDAQ:BMRC) is distributing a dividend of $0.25 per share with an annualized yield of 5.68%. The company has shown a positive trend in dividend per share from $0.80 in 2019 to $0.98 in 2022, and an increase in earnings per share from $2.52 to $2.81 over the same period. West Bancorp (NASDAQ:WTBA) has the highest annualized dividend yield among peers at 6.08%.

Portfolio Pulse from Benzinga Insights

November 10, 2023 | 3:05 pm

CZNC

WTBA

Citizens & Northern (NASDAQ:CZNC) is set to pay a dividend of $0.28 per share on November 10, 2023, with an annualized yield of 6.28%. Shareholders who held the stock before October 27, 2023, are eligible. The company has increased its dividend per share from $1.08 in 2020 to $1.12 in 2022, despite a decrease in earnings per share from $1.72 to $1.67 over the same period. This suggests a commitment to maintaining dividends amidst profitability challenges. Citizens & Northern's dividend yield surpasses that of West Bancorp (NASDAQ:WTBA), which has an annualized yield of 6.08%.

Portfolio Pulse from Benzinga Insights

November 10, 2023 | 3:05 pm

EGBN

MCBS

MetroCity Bankshares (NASDAQ:MCBS) is distributing a dividend of $0.18 per share today, with an annualized yield of 3.54%. The company has shown a positive trend with an increase in dividend per share from $0.40 in 2020 to $0.60 in 2022 and earnings per share growth from $1.46 in 2020 to $2.73 in 2022. This suggests a strong financial health and potential for future dividend increases. Eagle Bancorp (NASDAQ:EGBN) has the highest annualized dividend yield among peers at 8.40%.

Portfolio Pulse from Benzinga Insights

November 10, 2023 | 3:05 pm

GPP

USDP

Green Plains Partners (NASDAQ:GPP) is distributing a dividend of $0.46 per share with an annualized yield of 12.75%. The company has seen a decrease in both dividend per share and earnings per share from 2019 to 2022, indicating potential financial difficulties and impacting its ability to sustain dividends. USD Partners (NYSE:USDP) leads the industry with a 133.51% annualized dividend yield.

Portfolio Pulse from Benzinga Insights

November 10, 2023 | 3:05 pm

EMXC

Rep. Carol Miller reported purchasing iShares MSCI Emerging Markets ex China ETF (EMXC) stock valued between $65,002 and $150,000 on November 9, 2023. EMXC shares are up 1.35% at $51.0. Congressional transactions are monitored under the STOCK Act and are not primary indicators for investing decisions but can be considered by investors.

Portfolio Pulse from Benzinga Insights

November 10, 2023 | 3:05 pm

INUV

Inuvo shares were halted and then resumed trading, triggering a circuit breaker to the upside. The stock is currently up by 3.13%.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 3:03 pm

SKIN

Beauty Health (NASDAQ:SKIN) is scheduled to release its quarterly earnings report on Monday, 2023-11-13, with analysts expecting an EPS of $0.08. Investors are looking for an earnings beat and positive guidance for future growth. Historically, the company's stock price has been sensitive to earnings performance and guidance. Last quarter, SKIN missed EPS estimates by $0.02, leading to a 0.56% share price drop the following day. Over the past year, the stock has declined by 64.22%, indicating potential concern among long-term shareholders ahead of the earnings announcement.

Portfolio Pulse from Benzinga Insights

November 10, 2023 | 3:02 pm